An open-label, controlled study of citalopram versus moclobemide in patients with major depression

Current Therapeutic Research - Clinical and Experimental

Volumn 59, Issue 2, 1998, Pages 107-115

  Castanedo De Alba, Lauro ^a,c   Meixueiro Montes De Oca, Raul ^b  

^a HOSPITAL ESPAÑOL DE MÉXICO   (Mexico)

^b HOSPITAL ÁNGELES DEL PEDREGAL   (Mexico)

^c Clínica Eugenio Sue   (Mexico)

Author keywords

Antidepressant; Citalopram; Depression; Moclobemide

Indexed keywords

CITALOPRAM; MOCLOBEMIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SEROTONIN UPTAKE; TREMOR;

EID: 0031881792     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(98)85005-4     Document Type: Article

References (19)

1. Carlsson A. Physiological and pharmacological release of monoamines in the central nervous system. In: Euler US von Rosell, Uvnäs V, eds. Mechanisms of Release of Biogenic Amines. Oxford, United Kingdom: Pergamon Press; 1996:331-346.
2. Montgomery SA, Rasmussen GC, Lyby K, et al. Dose response relationship of citalopram 20 mg, citalopram 40 mg and placebo in the treatment of moderate and severe depression. Int Clin Psychopharmacol. 1992;5(Suppl 6):65-70.
3. Rosenberg C, Damsbo N, Fulgum E, et al. Citalopram and imipramine in the treatment of depressive patients in general practice. A Nordic multicentre clinical study. Int Clin Psychopharmacol. 1994;9(Suppl 1):41-48.
4. Milne R, Goa K. Citalopram: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in depressive illness. Drugs. 1991;41:450-477.
5. Hyttel J. Comparative pharmacology of selective serotonin re-uptake inhibitors (SSRIs). Clinical pharmacology in psychiatry: Focus on antidepressants. Nord J Psychiatry. 1993;47(Suppl 30):5-12.
6. Shaw DM, Harris B, Lloyd AT, et al. A comparison of the antidepressant action of citalopram and amitriptyline. Br J Psychiatry. 1986;149:515-517.
7. Bouchard JM, Delaunay J, Delisle JP, et al. Citalopram versus maprotiline. A controlled clinical multicentre trial in depressed patients. Acta Psychiatr Scand. 1987;76:583-592.
8. Andersen JP, Bech P, Benjaminsen S, et al. Citalopram: Clinical effect profiles in comparison with clomipramine. A controlled multicentre study. Psychopharmacology. 1986; 90:131-138.
9. De Wilde J, Mertens C, Fredrickson K, et al. Citalopram versus mianserin: A controlled, double-blind trial in depressed patients. Acta Psychiatr Scand. 1985;72:89-96.
10. Gottilieb P. Initial clinical trial of a new specific 5-HT reuptake inhibitor, citalopram. Acta Psychiatr Scand. 1980;62:236-244.
11. Lindegaard O, Kragh-Sorensen P, Bjerre M, et al. Citalopram, a selective serotonin reuptake inhibitor: Clinical antidepressive and long-term effect. A phase II study. Psychopharmacology. 1982;77:199-204.
12. Gastpar M, Gastpar G. Preliminary studies with citalopram (Lu-10-171), a specific 5-HT reuptake inhibitor, as antidepressant. Prog Neuro-Psychopharmacol Biol Psychiatry. 1982;6:319-325.
13. Guy W. ECDEU Assessment Manual for Psychopharmacology (modified). Rockville, Md: National Institute of Mental Health; 1976.
14. Lingjaerde O, Ahlofors UG, Bechh P, et al. The UKU side effect rating scale. Acta Psychiatr Scand. 1987;76(Suppl 334):85-100.
15. Ofsti E. Citalopram - a specific 5-HT reuptake inhibitor - as antidepressant drug: A phase II multicentre trial. Prog Neuro-Psychopharmacol Biol Psychiatry. 1982;6:327-335.
16. Timmerman L, De Beurs P, Tan BK, et al. A double-blind comparative trial of citalopram vs maprotiline in hospitalized depressed patients. Int Clin Psychopharmacol. 1987;2:239-253.
17. Feldmann HS, Denber HC. Long term study of fluvoxamine. A new rapid-acting antidepressant. Int Pharmacopsychiatry. 1982;46:114-122.
18. Feighner JP. A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder. J Clin Psychiatry. 1985;46:369-372.
19. Nyström C, Hällström T. Double-blind comparison between a serotonin and a noradrenaline re-uptake blocker in the treatment of depressed outpatients. Acta Psychiatr Scand. 1985;72:6-15.